| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/29/1997 | WO1997019107A1 Identification of antigenes from post-infection nematodes for the purpose of developing new anthelmintics and vaccines |
| 05/29/1997 | WO1997019106A2 Collagen-like peptoid residue-containing structures |
| 05/29/1997 | WO1997019105A1 Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds. |
| 05/29/1997 | WO1997019103A1 Novel synthetic substrate for activity assay having chromophore or fluorochromophore active against hepatitis c virus ns3 protease |
| 05/29/1997 | WO1997019101A1 Novel grb2 associating polypeptides and nucleic acids encoding therefor |
| 05/29/1997 | WO1997019098A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
| 05/29/1997 | WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | WO1997018834A1 Therapeutic fragments of von willebrand factor |
| 05/29/1997 | WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | WO1997018832A1 Interferon-polymer conjugates and process for preparing the same |
| 05/29/1997 | WO1997018829A1 Cartilage/bone inducing materials for reparation |
| 05/29/1997 | WO1997018827A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | WO1997018825A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018708A1 Broad spectrum antibiotic peptide |
| 05/29/1997 | WO1997009343A3 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 05/29/1997 | WO1997004748A3 Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | CA2238610A1 Fine tuned protegrins |
| 05/29/1997 | CA2238429A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238290A1 Methods for determining compounds capable of inhibiting the activities of the ha-ras oncogene |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2238075A1 Protein which interacts with the huntington's disease gene product, cdna coding therefor, and antibodies thereto |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2237845A1 Collagen-like peptoid residue-containing structures |
| 05/29/1997 | CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | CA2236162A1 Epithelial membrane protein-1 |
| 05/29/1997 | CA2210016A1 Trypsin inhibitor protein from pentaclethra macroloba having insecticidal properties |
| 05/28/1997 | EP0775750A2 Preparation of proteins from pro-proteins by fusion proteins derived from furin or furinanalogs |
| 05/28/1997 | EP0775749A1 Subtilisin mutants |
| 05/28/1997 | EP0775747A2 Genes of the hop latent virus and methods for detecting the same |
| 05/28/1997 | EP0775746A2 Coccidiosis poultry vaccine |
| 05/28/1997 | EP0775743A2 Sustainable chick cell line infected with Marek's disease virus |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775711A1 Peptide having antithrombotic activity and process for producing the same |
| 05/28/1997 | EP0775710A1 Ultafiltrations as prepurification step for proteins and peptides from cell-freeculture media |
| 05/28/1997 | EP0775212A2 Control of plant gene expression |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775208A2 Insect viruses, sequences, insecticidal compositions and methods of use |
| 05/28/1997 | EP0775207A1 Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775201A2 An improved cleaning composition |
| 05/28/1997 | EP0775198A1 Molecular presenting system |
| 05/28/1997 | EP0775160A1 Cyclic hexapeptide somatostatin analogues |
| 05/28/1997 | EP0775159A1 Novel process for the production of biologically active dimeric protein |
| 05/28/1997 | EP0775157A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 05/28/1997 | EP0774971A1 Synthetic peptide inhibitors of hiv transmission |
| 05/28/1997 | EP0687273B1 Collagenase activity inhibitor and cosmetic composition containing same |
| 05/28/1997 | EP0653064A4 Clinical test for detection of alzheimer's disease. |
| 05/28/1997 | EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 05/28/1997 | EP0455705B1 Receptor membranes and ionophore gating |
| 05/28/1997 | DE19543628A1 Humanes, im Blut zirkulierendes Peptid mit insulinotroper Wirkung (GCAP-II-(89-112), (Guanylyl Cyclase C Aktivierendes Peptid II) und seine GCAP-Analoga, insbesondere das GCAP-I-(99-115), seine Anwendung als pharmakologischer Wirkstoff und Benutzung seines Wirkungsprinzipes zur Bereitstellung neuer GC-C-abhängiger insulinotroper Wirkstoffe Human, circulating in the blood insulinotropic peptide effect (GCAP-II (89-112), (guanylyl cyclase-activating peptide C II) and its GCAP analogues, in particular the GCAP-I (99-115), its use as a pharmacological drug use and its effect principle to provide new GC-C-dependent insulinotropic drugs |
| 05/28/1997 | DE19543554A1 Identifizierung von Antigenen aus post-infektiösen Nematoden zur Entwicklung neuer Anthelmintika und Vakzinen Identification of antigens from post-infective nematodes to develop new vaccines and anthelmintics |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | CN1150840A A method for detecting presence of mycobacterium species and kit and antibodies for use therein |
| 05/28/1997 | CN1150819A Vaccine against mumps containing jeryl-Lynn virus strain |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150756A Stable protein: phospholipid composition and method |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1150602A Human thymosin alpha-source and preparing method thereof |
| 05/28/1997 | CN1150601A Bacteriocin |
| 05/27/1997 | US5633451 Having significant thermal hysteresis activity |
| 05/27/1997 | US5633449 A dna molecule |
| 05/27/1997 | US5633446 Modified Bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
| 05/27/1997 | US5633442 Method of producing pathogen-resistant plants |
| 05/27/1997 | US5633441 Genetic engineering |
| 05/27/1997 | US5633438 Isolated dna molecule |
| 05/27/1997 | US5633436 Chimeric gene which causes increase in total seed methionine in plant cells expressing gene |
| 05/27/1997 | US5633434 Transgenic plants displaying virus and phosphinothricin resistance |
| 05/27/1997 | US5633433 Dna clone for rubber biosynthesis |
| 05/27/1997 | US5633425 Transgenic non-human animals capable of producing heterologous antibodies |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/27/1997 | US5633363 Root preferential promoter |
| 05/27/1997 | US5633352 Biosynthetic human growth hormone |
| 05/27/1997 | US5633351 Targeting protein-diagnostic/therapeutic agent conjugates having Schiff base linkages |
| 05/27/1997 | US5633350 Method for the isolation and purification of vitamin K-dependent proteins |
| 05/27/1997 | US5633348 Amphotropic virus receptor |
| 05/27/1997 | US5633347 Treatment of small-cell lung carcinomas |
| 05/27/1997 | US5633263 Linear somatostatin analogs |
| 05/27/1997 | US5633234 Lysosomal targeting of immunogens |
| 05/27/1997 | US5633229 Method of using prophenins-antibiotic peptides |
| 05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 05/27/1997 | US5633165 Fermentor with vertical shaft |
| 05/27/1997 | US5633161 Murine gene fomy030 coding for tumor progression inhibitor |
| 05/27/1997 | US5633155 Expression vector for phytolacca antiviral protein and process for preparing transgenic plant transformed therewith |
| 05/27/1997 | US5633154 Method for location of insertion elements |
| 05/27/1997 | US5633152 Genetic engineering and expression |
| 05/27/1997 | US5633150 Preparation of functional human factor VIII |
| 05/27/1997 | US5633149 Polynucleotide encoding novel chemokine expressed in inflamed adenoid |
| 05/27/1997 | US5633148 Genetic engineering |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5633145 TNFα receptor-derived binding protein |